02/09/2015 - 12:34pm

Mylan Inc. and its subsidiary Mylan Pharmaceuticals are being sued by Bayer Healthcare, Bayer Healthcare Pharmaceuticals and Onyx Pharamceuticals in relation to the filing of an abbreviated new drug application for sorafenib tablets, the generic version of Nexavar. 

 

02/06/2015 - 11:55am

The pharma industry praised outgoing Food and Drug Administration commissioner Margaret Hamburg and welcomed Stephen Ostroff, who will assume the role of acting commissioner.

02/05/2015 - 2:45pm

Food and Drug Commissioner Margaret Hamburg will resign from her post in March.

 

02/05/2015 - 1:16pm

The Venezeulan government has continued its crackdown on retail in the country for allegedly hoarding products.

02/05/2015 - 11:43am

Generic drug prices are going up. Spurred by market opportunities, short-term market exclusivity for some newly launched single-source generics and rising costs for manufacturing, quality control and raw materials, me-too drug manufacturers have escalated a series of price hikes, some of them significant.

02/05/2015 - 11:42am

In this issue, DSN looks at another three hot spot issues identified by PwC’s HRI that will help define how health care is provided in 2015.

02/05/2015 - 11:16am

HDMA recognized four members of Congress with the Association’s Rx Safety and Healthcare Leadership Award.

02/03/2015 - 3:25pm

Zogenix last week announced that the Food and Drug Administration approved a new formulation of the company's Zohydro ER (hydrocodone bitartrate) extended-release capsules, CII.

02/03/2015 - 3:06pm

Boehringer Ingelheim Pharmaceuticals and Eli Lilly and Co. on Monday announced that the Food and Drug Administration has approved Glyxambi (empagliflozin/linagliptin) tablets.